Allodynia affects a small minority of semaglutide users
Safety concerns also surfaced: the FDA has linked compounded semaglutide to adverse events, including dosing errors that led to hospitalizations and, in certain cases, more serious outcomes
In a recent study, researchers discovered that GLP-1 receptor activation in the brain can effectively suppress inflammation triggered by various factors, suggesting a potential mechanism for neuroprotection
Maternal Immune Activation Therapeutics Maternal immune activation (MIA), or the initiation of inflammatory pathways during pregnancy, has been associated with the pathogenesis of neurodevelopmental disorders, including ASD [45,46,47]
Leaning on liquid calories